BACKGROUND: Tumor thickness (TT) appears to be a strong predictor for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity (OSCC), but a precise clinically optimal TT cutoff point has not been established. To address this question, the authors conducted a meta-analysis. METHODS: All relevant articles were identified from MEDLINE and EMBASE as well as from cross-referenced publications cited in relevant articles. Lymph-node involvement was confirmed and identified as positive lymph-node declaration (P(LN)D) by either pathologic positivity on immediate neck dissection or by neck recurrence identified after follow-up > or = 2 years. Odds ratios (OR) were calculated to quantify the predictive value of TT. Negative predictive values (and the percentage of patients falsely predicted to not have P(LN)D [FN-P(LN)D]) were compared to determine the optimal TT cutoff point. RESULTS: Sixteen studies were selected from 72 potential studies, yielding a pooled total of 1136 patients. Data were examined for the following TT cutoff points: 3 mm (4 studies, 387 patients), 4 mm (9 studies, 778 patients), 5 mm (6 studies, 367 patients), and 6 mm (4 studies, 488 patients). The OR (95% CI) was 7.3 (5.3-10.1) for the overall group. The proportion of FN-P(LN)D was 5.3% (95% CI, 2.0-11.2), 4.5% (2.6-7.2), 16.6% (11.5-22.8), and 13.0% (9.7-16.9) for TT<3, <4, <5, and <6 mm, respectively. There was a statistically significant difference between the 4-mm and 5-mm TT cutoff points (P = .007). CONCLUSIONS: TT was a strong predictor for cervical lymph-node involvement. The optimal TT cutoff point was 4 mm. (c) 2009 American Cancer Society
BACKGROUND:Tumor thickness (TT) appears to be a strong predictor for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity (OSCC), but a precise clinically optimal TT cutoff point has not been established. To address this question, the authors conducted a meta-analysis. METHODS: All relevant articles were identified from MEDLINE and EMBASE as well as from cross-referenced publications cited in relevant articles. Lymph-node involvement was confirmed and identified as positive lymph-node declaration (P(LN)D) by either pathologic positivity on immediate neck dissection or by neck recurrence identified after follow-up > or = 2 years. Odds ratios (OR) were calculated to quantify the predictive value of TT. Negative predictive values (and the percentage of patients falsely predicted to not have P(LN)D [FN-P(LN)D]) were compared to determine the optimal TT cutoff point. RESULTS: Sixteen studies were selected from 72 potential studies, yielding a pooled total of 1136 patients. Data were examined for the following TT cutoff points: 3 mm (4 studies, 387 patients), 4 mm (9 studies, 778 patients), 5 mm (6 studies, 367 patients), and 6 mm (4 studies, 488 patients). The OR (95% CI) was 7.3 (5.3-10.1) for the overall group. The proportion of FN-P(LN)D was 5.3% (95% CI, 2.0-11.2), 4.5% (2.6-7.2), 16.6% (11.5-22.8), and 13.0% (9.7-16.9) for TT<3, <4, <5, and <6 mm, respectively. There was a statistically significant difference between the 4-mm and 5-mm TT cutoff points (P = .007). CONCLUSIONS: TT was a strong predictor for cervical lymph-node involvement. The optimal TT cutoff point was 4 mm. (c) 2009 American Cancer Society
Authors: Alhadi Almangush; Ibrahim O Bello; Ricardo D Coletta; Antti A Mäkitie; Laura K Mäkinen; Joonas H Kauppila; Matti Pukkila; Jaana Hagström; Jussi Laranne; Ylermi Soini; Veli-Matti Kosma; Petri Koivunen; Natalie Kelner; Luiz Paulo Kowalski; Reidar Grénman; Ilmo Leivo; Esa Läärä; Tuula Salo Journal: Virchows Arch Date: 2015-04-03 Impact factor: 4.064
Authors: Shaum Sridharan; Lester D R Thompson; Bibianna Purgina; Charles D Sturgis; Akeesha A Shah; Brian Burkey; Madalina Tuluc; David Cognetti; Bin Xu; Kevin Higgins; Juan C Hernandez-Prera; Dominick Guerrero; Manish M Bundele; Seungwon Kim; Umamaheswar Duvvuri; Robert L Ferris; William E Gooding; Simion I Chiosea Journal: Cancer Date: 2019-06-07 Impact factor: 6.860
Authors: Hussain Fatakdawala; Shannon Poti; Feifei Zhou; Yang Sun; Julien Bec; Jing Liu; Diego R Yankelevich; Steven P Tinling; Regina F Gandour-Edwards; D Gregory Farwell; Laura Marcu Journal: Biomed Opt Express Date: 2013-08-26 Impact factor: 3.732
Authors: Babak Givi; Antoine Eskander; Mahmoud I Awad; Qin Kong; Pablo H Montero; Frank L Palmer; Wei Xu; John R De Almeida; Nancy Lee; Brian O'Sullivan; Jonathan C Irish; Ralph Gilbert; Ian Ganly; Snehal G Patel; David P Goldstein; Luc G T Morris Journal: Head Neck Date: 2015-11-28 Impact factor: 3.147
Authors: Wouter L Lodder; Hendrik J Teertstra; Ing B Tan; Frank A Pameijer; Ludi E Smeele; Marie-Louise F van Velthuysen; Michiel W M van den Brekel Journal: Eur Radiol Date: 2010-08-03 Impact factor: 5.315